DDIF
Attend.

DDIF 2027 · Partner positions

A position.
Not a
placement.

Fourteen pages. Six positions. One standard across every forum in the circle. Each position is held for one organisation per forum, per year.

The positions

Positions are shared in the prospectus, on request. They are not published.

request the prospectus

Curated for

A position is worth what the room is worth. These are the functions the sessions are written for, and the organisations the invitation goes to.

The functions the agenda is written for

Head of Drug Discovery

Owns the decision the forum is named for. Every session sits between a target and a compound worth carrying.

Head of AI Strategy & Autonomous Operations

Where AI changes the compound, not the slide. The intelligence layer runs through every forum, and here it meets the discovery decision itself.

Head of Target Identification & Validation

The earliest decision and the most expensive one to get wrong. Everything downstream inherits it.

Head of Lead Optimisation

Where a molecule becomes a candidate or becomes a sunk cost. A named session, because the call is rarely clean.

Head of CMC

Carries the compound from bench to something that can be made.

Head of Translational Medicine

The gap between a model that works and a patient who responds. The room exists because it is still a gap.

VP Clinical Operations

Published as a discipline. Turns a development plan into sites, patients and dates.

Head of Regulatory Strategy

Published as a discipline. Reads the path before the programme commits to it.

Head of Commercial Development

Published as a discipline. Decides what a compound is worth before the science is finished telling you.

Head of Enabling Technology

Published as a discipline, and the one the other nine increasingly depend on.

The organisations the invitation goes to

AstraZeneca
GSK
Roche
Novartis
Sanofi
Bayer
Boehringer Ingelheim
Merck KGaA
Novo Nordisk
MSD
Lundbeck
UCB
Galapagos
argenx
BioNTech
Evotec
Pfizer
Eli Lilly
Johnson & Johnson
Bristol Myers Squibb
AbbVie
Gilead
Amgen
Vertex
Regeneron
Moderna
Genentech
Takeda
Daiichi Sankyo
Astellas
Altos Labs
Generate Biomedicines
DaltonTx
Dotmatics
Servier
Ipsen

Thirty-six organisations. Up to 150 senior leaders. The Savoy, London.